Sharon Pattison

1.2k total citations · 1 hit paper
31 papers, 482 citations indexed

About

Sharon Pattison is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Sharon Pattison has authored 31 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 11 papers in Pulmonary and Respiratory Medicine and 9 papers in Molecular Biology. Recurrent topics in Sharon Pattison's work include Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (7 papers) and Neuroendocrine Tumor Research Advances (5 papers). Sharon Pattison is often cited by papers focused on Pancreatic and Hepatic Oncology Research (7 papers), Cancer Genomics and Diagnostics (7 papers) and Neuroendocrine Tumor Research Advances (5 papers). Sharon Pattison collaborates with scholars based in New Zealand, Australia and United States. Sharon Pattison's co-authors include Andrew Reynolds, Rhiannon Braund, Ann Roman, David G. Skalnik, Sarah L. Young, Silke Neumann, Rita A. Busuttil, Alex Boussioutas, Euan J. Rodger and John McCall and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Virology.

In The Last Decade

Sharon Pattison

30 papers receiving 477 citations

Hit Papers

Proton pump inhibitor use: systematic review of global tr... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sharon Pattison New Zealand 12 161 147 102 87 85 31 482
Wenqing Hu China 14 140 0.9× 146 1.0× 87 0.9× 66 0.8× 83 1.0× 62 452
Simona Faraci Italy 12 153 1.0× 141 1.0× 143 1.4× 62 0.7× 138 1.6× 25 452
Heikki Huhta Finland 13 182 1.1× 114 0.8× 119 1.2× 93 1.1× 162 1.9× 55 537
Lindsay Alpert United States 13 184 1.1× 139 0.9× 111 1.1× 59 0.7× 141 1.7× 47 578
Masato Ueno Japan 15 97 0.6× 157 1.1× 100 1.0× 71 0.8× 147 1.7× 38 463
Andreas Giannakou United States 12 145 0.9× 200 1.4× 60 0.6× 65 0.7× 137 1.6× 25 533
Tasneem Ahmed United States 9 78 0.5× 142 1.0× 79 0.8× 27 0.3× 145 1.7× 18 468
Kajsa E. Affolter United States 11 233 1.4× 67 0.5× 94 0.9× 49 0.6× 112 1.3× 26 390
Masayo Tsukamoto Japan 13 297 1.8× 150 1.0× 115 1.1× 112 1.3× 235 2.8× 36 612

Countries citing papers authored by Sharon Pattison

Since Specialization
Citations

This map shows the geographic impact of Sharon Pattison's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Pattison with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Pattison more than expected).

Fields of papers citing papers by Sharon Pattison

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sharon Pattison. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Pattison. The network helps show where Sharon Pattison may publish in the future.

Co-authorship network of co-authors of Sharon Pattison

This figure shows the co-authorship network connecting the top 25 collaborators of Sharon Pattison. A scholar is included among the top collaborators of Sharon Pattison based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sharon Pattison. Sharon Pattison is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pattison, Sharon, et al.. (2024). Discovery of prognostic lncRNAs in colorectal cancer using spatial transcriptomics. npj Precision Oncology. 8(1). 230–230. 4 indexed citations
2.
Mendis, Shehara, Lara Lipton, Sumitra Ananda, et al.. (2024). Early onset pancreatic cancer—exploring contemporary treatment and outcomes using real-world data. British Journal of Cancer. 130(9). 1477–1484. 4 indexed citations
3.
Pattison, Sharon, et al.. (2024). Exploring Potential Epigenetic Biomarkers for Colorectal Cancer Metastasis. International Journal of Molecular Sciences. 25(2). 874–874. 11 indexed citations
4.
Gimenez, Grégory, Peter A. Stockwell, Anna L. Leichter, et al.. (2023). DNA Methylome and Transcriptome Maps of Primary Colorectal Cancer and Matched Liver Metastasis. Data. 9(1). 8–8. 1 indexed citations
5.
Rodger, Euan J., Grégory Gimenez, Peter A. Stockwell, et al.. (2023). An epigenetic signature of advanced colorectal cancer metastasis. iScience. 26(6). 106986–106986. 16 indexed citations
7.
Gray, Elin S., et al.. (2022). Size-Based Method for Enrichment of Circulating Tumor Cells from Blood of Colorectal Cancer Patients. Methods in molecular biology. 2588. 231–248. 3 indexed citations
8.
Eccles, Michael R., Euan J. Rodger, Sharon Pattison, et al.. (2021). The Epigenetic landscape of Circulating tumour cells. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1875(2). 188514–188514. 25 indexed citations
9.
Elston, Marianne S., Dev Kevat, Richard Carroll, et al.. (2021). Pituitary function following peptide receptor radionuclide therapy for neuroendocrine tumours. Cancer Medicine. 10(23). 8405–8411. 7 indexed citations
10.
Lee, Belinda, Shehara Mendis, Benjamin Thomson, et al.. (2021). Investigating real-world treatment sequencing outcomes in advanced pancreatic cancer: A purple translational registry analysis.. Journal of Clinical Oncology. 39(3_suppl). 386–386. 1 indexed citations
11.
Busuttil, Rita A., Joshy George, Colin M. House, et al.. (2020). SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence. Gastric Cancer. 24(3). 589–601. 13 indexed citations
12.
Neumann, Silke, et al.. (2020). The Effects of Obesity on Anti-Cancer Immunity and Cancer Immunotherapy. Cancers. 12(5). 1230–1230. 75 indexed citations
13.
Pattison, Sharon, Eva Segelov, Simron Singh, et al.. (2019). Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care. Journal of Clinical Medicine. 8(9). 1455–1455. 6 indexed citations
14.
Pattison, Sharon, Catherine Mitchell, Stephen Lade, et al.. (2017). Early relapses after adjuvant chemotherapy suggests primary chemoresistance in diffuse gastric cancer. PLoS ONE. 12(9). e0183891–e0183891. 21 indexed citations
15.
Wang, Minyu, Rita A. Busuttil, Sharon Pattison, Paul J. Neeson, & Alex Boussioutas. (2016). Immunological battlefield in gastric cancer and role of immunotherapies. World Journal of Gastroenterology. 22(28). 6373–6373. 27 indexed citations
16.
Pattison, Sharon & John Zalcberg. (2014). Bespoke treatment: Drivers beware!. Asia-Pacific Journal of Clinical Oncology. 10(4). 378–380. 1 indexed citations
17.
Pattison, Sharon, et al.. (2013). Triple negative breast cancer in a male‐to‐female transsexual. Internal Medicine Journal. 43(2). 203–205. 28 indexed citations
18.
Futschik, Matthias E., Aaron Jeffs, Sharon Pattison, et al.. (2002). Gene Expression Profiling of Metastatic and Nonmetastatic Colorectal Cancer Cell Lines. 1(1). 26–34. 28 indexed citations
19.
Pattison, Sharon, Simon Choong, Cathy Corbishley, & Michael Bailey. (2001). Squamous cell carcinoma of the bladder, intermittent self‐catheterization and urinary tract infection—is there an association?. British Journal of Urology. 88(4). 441–441. 6 indexed citations
20.
Farr, Andrew G., Sharon Pattison, Byung‐Soo Youn, & Ann Roman. (1995). Detection of silencer activity in the long control regions of human papillomavirus type 6 isolated from both benign and malignant lesions. Journal of General Virology. 76(4). 827–835. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026